Results 91 to 100 of about 39,848 (225)

Incidencia de trombosis de stents coronarios en el «mundo real» Incidence of coronary stent thrombosis in the «real world»

Revista Colombiana de Cardiología, 2010
ANTECEDENTES: la evidencia disponible de stents liberadores de medicamento proviene de estudios controlados con estrictos criterios de inclusión, limitando sus conclusiones y haciendo difícil la aplicación de sus resultados en el mundo real.
Bernardo Lombo, Rendón, Claudia Satizábal, Carolina Rivas, Daniel Sarmiento, Carlos Carvajal, Jorge Mor, José G Diez   +7 more
doaj  

Análise de impacto do stent farmacológico no orçamento do sistema único de saúde Impact analysis of drug-eluting stent in the unified health system budget

Arquivos Brasileiros de Cardiologia, 2007
FUNDAMENTO: Stents farmacológicos representam opção adicional para o tratamento da doença arterial coronariana. Essa tecnologia representa importante inovação, para a qual pode ser necessário financiamento adicional, no curto prazo, para permitir ...
Denizar Vianna Araújo, Valter Correia Lima, Marcos Bosi Ferraz   +2 more
doaj   +1 more source

Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stent for In‐Stent Restenosis and De‐Novo Lesions: A Meta‐Analysis of Randomized Controlled Trials

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) are commonly used in percutaneous coronary interventions (PCI), but their long‐term comparative effectiveness remains unclear. This meta‐analysis aimed to compare the clinical and angiographic outcomes of DCB versus DES in patients with in‐stent restenosis (ISR) and
Arman Soltani Moghadam, Sina Kazemian, Shayan Shojaei, Saman Soltani Moghadam, Reza Hosseini Dolama, Rasoul Ebrahimi, Fatemeh Ojaghi Shirmard, Seyed Morteza Ali Pourfaraji, Mohammad Sadeq Najafi, Sara Hobaby, Hamidreza Soleimani, Masih Tajdini, Behnam Tehrani, Dhaval Kolte, Islam Elgendy, Sandeep Basavarajaiah, Azeem Latib, Yasar Sattar, M. Chadi Alraies, Kaveh Hosseini   +19 more
wiley   +1 more source

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature

Heart Views, 2011
Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga, Mohammed Al-Mukhaini   +1 more
doaj   +1 more source

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI [PDF]

, 2017
BACKGROUND: Coronary revascularization guided by fractional flow reserve (FFR) is associated with better patient outcomes after the procedure than revascularization guided by angiography alone.
Al-Lamee, R, Baptista, SB, et al., Davies, J, Dehbi, M, Nijjer SS1, S, Petraco, R, Sen, S   +6 more
core   +1 more source

Actual problems of stenting using in critical limb ischemia (cli) treatment

Ендоваскулярна нейрорентгенохірургія, 2017
Critical limb ischemia is a life-threatening disease that often results in partial disability or death. One of the ways in optimizing its endovascular treatment is the stents using.
O.L. Nikishin, MI. Muz, A.I. Gavretskiy, I.V. Altman, S.I. Savoluk   +4 more
doaj   +1 more source

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis

Coronary Artery Disease, 2019
Approximately, 10-20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated implantation of new-generation DES.A total of 172 ...
Wang, Guozhong, Zhao, Quanming, Chen, Qing, Zhang, Xiaoxia, Tian, Lei, Zhang, Xiaojiang   +5 more
openaire   +3 more sources

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

Biologics: Targets & Therapy, 2013
Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj  

Research progress of drug eluting balloon in arterial circulatory system

Frontiers in Cardiovascular Medicine
The arterial circulatory system diseases are common in clinical practice, and their treatment options have been of great interest due to their high morbidity and mortality.
Keji Lu, Keji Lu, Xianglin Ye, Xianglin Ye, Yaoxuan Chen, Peng Wang, Meiting Gong, Bing Xuan, Zhaobing Tang, Meiling Li, Jun Hou, Ke Peng, Haifeng Pei, Haifeng Pei   +13 more
doaj   +1 more source